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Summary 
Nitric  oxide (NO)  is a short-lived biologic mediator  that  is shown to be induced in various 
cell types and to cause many metabolic changes in target cells. Inhibition of tumor cell growth 
and antimicrobial  activity has been attributed  to the stimulation  of the inducible type of the 
NO synthase (NOS). However, there is limited evidence for the existence of such inducible NOS 
in a human cell type. We show here the induction of NO biosynthesis in freshly isolated human 
hepatocytes (HC) after stimulation  with interleukin  1,  tumor necrosis factor (TNF),  IFN-% 
and endotoxin.  Increased levels of nitrite  (NO2-)  and nitrate  (N03-)  in culture supernatants 
were associated with NADPH-dependent  NOS activity in the cell lysates.  The production of 
NO2-  and  N03-  was  inhibited  by N6-monomethyl  I.-arginine  and  was associated with  an 
increase in cyclic guanylate monophosphate release.  The data presented here provide evidence 
for the existence of typical inducible NO biosynthesis in  a human  cell type. 
A  variety of cell types have been shown to produce nitric 
oxide (NO)  from t-arginine  by either  a constitutive 
and/or an inducible enzyme (1). Recent reports provide strong 
evidence that vasorelaxation, induced through the constitu- 
tive and inducible NO pathway,  might  play an important 
role in the regulation of vascular tone in humans (2, 3). Little 
evidence for the existence of inducible NO enzyme activity 
in specific human  cell types has been documented,  despite 
its clear potential role in the elimination of tumor cells (4) 
and intra- and extracellular pathogens (recently reviewed in 
reference 5), as well as in the induction of sustained hypoten- 
sion  (6),  as shown in animal  models. 
We have shown that rat hepatocytes (HC) cocultured with 
Kupffer ceils  and  stimulated  with  LPS can produce large 
amounts of nitrite  (NO2-)  and nitrate  (N03-),  the stable 
end products of NO (7). Furthermore,  we have shown that 
HC alone are capable of biosynthesis of NO when exposed 
to various immunostimuli (8-10). The expression of the in- 
ducible nitric oxide synthase (NOS) alters various HC func- 
tions in vitro.  These include a substantial  decrease in total 
protein synthesis (7, 11), the inhibition of mitochondrial aconi- 
tase (12), and the stimulation of cyclic guanylate monophos- 
phate (cGMP) synthesis and release (13). In vivo studies sug- 
gest that hepatic NO can protect the liver from damage in 
sepsis (14). In this communication,  we report that nitrogen 
oxides are also produced in large amounts by human HC in 
a reproducible manner, demonstrating that a human call type 
can,  indeed,  express an inducible NOS. 
Materials  and Methods 
Culture Medium.  HC cultures  were performed  in  Williams 
medium E (Gibco Laboratories, Grand Island, NY) supplemented 
with 10 .6 M insulin, 15 mM Hepes, t-glutamine, penicillin, strep- 
tomycin, and 10% dialyzed calf serum. Additional culture reagents 
included t-arginine  hydrochloride  (Gibco Laboratories) and N ~- 
monomethyl-r-arginine acetate (NMA), prepared by a modification 
of the method previously described (15). 
Hepatocyte Isolation.  In accordance with institutional  review 
guidelines, human  HC were isolated from histologically normal 
wedge sections of liver resection specimens by collagenase (0.5%, 
type A; Boehringer Ingelheim, Germany) perfusion. Immediately 
after isolation, HC were purified over a Percoll gradient to obtain 
a highly purified cell population (16). After this procedure, purity 
exceeded 97% (assessed  by microscopy) and viability ranged from 
89 to 99% by trypan blue exclusion. HC (2  x  10  s) were cultured 
in 24-well tissue culture  trays and incubated  with  5%  CO2 at 
37~  for 24 h before use in experiments. 
Cell Culture Technique.  HC were incubated with 0.5 ml of ei- 
ther a mixture of 10 #g/ml LPS (Escherichia coli, 011:B~; Sigma 
Chemical Co., St. Louis, MO), 5 U/ml human recombinant  (rh) 
IL-1B (Cistron), 500 U/ml rhTNF-ol (C-enzyme, Boston, MA), and 
100 U/ml rhlFN-3,  (Amgen  Biologicals, Thousand Oaks,  CA), 
or various combinations  of these signals for 24 and 48 h. At the 
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NO3- and extracellular cGMP levels determined. When indicated, 
0.1 mM NMA with or without 2.0 mM t-arginine  was added to 
the cultures with the signals. The presence of calmodulin inhibi- 
tots (10/~M trifluoperazine,  10/~M W5  [N-(6-aminohexyl)-5- 
chloro-2-naphthalenesulfonamide]) on HC NO2- and NO~- for- 
mation was also tested. 
Preparation of Cytosol.  Either  control HC in culture  or HC 
stimulated with cytokines and LPS were scraped up and pelleted 
at 250 g for 5 rain (24 h after the addition of the signals). H~O 
with protease inhibitors (5/~g/ml aprotinin, 0.1 mM PMSF, 5/~g/ml 
pepstatin A, and 1 #g/ml chymostatin) was added to 10  s HC/ml, 
and the cells were lysed by three rapid freeze/thaw cycles. A 100,000 
g, supernatant  was used for the enzyme assay as described (10). 
Determination of NO2-~NO3- and cGMP.  cGMP levels were 
measured using a commercially available radioimmunoassay (Amer- 
sham Corp.,  Arlington  Heights,  IL) that had a sensitivity range 
of 2-128 fmol/assay sample. To assess the amount of NO produced, 
the culture supernatants were assayed for the stable end products 
of NO, NO2-, and NO3- with an automated procedure based on 
the Griess reaction,  as previously described (7). 
Results and Discussion 
The  stimulation  of human  HC with  a combination  of 
rhTNF-c~,  rhlL-1-B,  rhlFN-% and LPS resulted in a marked 
increase in NO2-  and N03 -  in supernatants of human HC 
isolated from liver specimens from seven separate individuals 
(Fig.  1).  The  NO2-/N03-  levels  were  over  three  times 
higher at 48 h than 24 h (Fig.  2). The addition  of NMA, 
a competitive inhibitor  of NO synthesis (4),  almost  com- 
pletely suppressed NO2-/NO3-  production  at both  time 
points,  an effect that  could be partially overcome by addi- 
tional t-arginine (2.0 raM). The addition of calmodulin in- 
hibitors, trifluoperazine, and W5 (10/~M) had no significant 
effect on HC NO synthesis in response to cytokines plus LPS 
(data not shown). This resuh is in keeping with earlier ob- 
servations,  showing that the inducible NOS does not depend 
on the presence of Ca  2  + or calmodulin  (1). 
The cytokines IL1B, IFN-% and TNF-ot have been shown 
to increase the expression of inducible NOS in several rodent 
cell types (1). These single cytokines or LPS did not increase 
NO2-/NO3-  formation in human  HC over control levels 
after either 24 or 48 h of incubation (Table 1). Combinations 
of two of these signals (six combinations) induced only minor 
(<5%)  increases  in  NO2-/NO3-  synthesis.  Of the  four 
possible combinations of three signals,  the combination of 
TNF/IL-1/IFN-'y  was  most  effective with  NO2-/NO3- 
levels reaching 67% of the maximum  seen at 24 h with all 
four signals  (three  =  25.4  _+ 2.9, four  =  37.8  _+ 2.0). NO 
is a potent inducer of soluble guanylate cyclase resuhing in 
increased cGMP production. Through this action, NO plays 
a role in smooth muscle relaxation (17), signaling in the cen- 
tral nerve system (18), and reduced platelet aggregation and 
adherence (19). We have recently shown that rat HC release 
large  amounts  of cGMP coincident  with  the  synthesis  of 
NO2-/NO3-  after cytokine and LPS stimulation (13). After 
24 h in culture, human HC were found to have released small 
amounts  of cGMP  if unstimulated  or  exposed  to  single 
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Figure  1.  NOz- and NO3- levels in human HC supernatant 24 h after 
exposure  to a mixture of cytokines and LPS. Markedly elevated levels of 
NO2-  and NO3-  were found in all stimulated cultures (ll) when com- 
pared with nonstimulated (D). Results show the mean _+ SEM for tripli- 
cate cultures from seven different individuals. 
cytokines or LPS (Table  1). NMA reduced both the cGMP 
and NO2-/NO3-  generation,  suggesting that low levels of 
NO may be produced under these conditions. When exposed 
to the combination of four signals, a marked increase in cGMP 
release  was associated with  high  NO2-/N03-  synthesis. 
This cGMP release was inhibited by NMA, suggesting that 
the increased cGMP release was due to NO synthesis, cGMP 
levels were actually lower by the 48-h time point. This reduc- 
tion in supernatant cGMP might be explained by the pres- 
ence of phosphodiesterases  (20). 
Reconstitution of enzyme activity for NO synthesis in cyto- 
solic preparations from both rat HC (10) and other cell types 
(1) requires the addition of NADPH. Cytosol was obtained 
from  cultured  human  HC  24  h  after  stimulation  with 
cytokines and LPS.  The addition of L-arginine  (8 mM), or 
NADPH (0.1  mM) alone,  resulted in 0.84 nmol/mg  pro- 
tein/3 h and 0.05 nmol NOz-/mg protein/3 h, respectively. 
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Figure  2.  Human HC were stimulated as described above.  Superna- 
tants from control (C])  and  stimulated cuhures (11)  were  tested for 
NOe-/NO3-  24  and  48  h  later.  To  determine  if  the  source  of 
NOz-/NO3 -  was via the induction of NOS, cells were incubated in the 
presence  of NMA (0.1 raM) ([]) or with NMA plus the simultaneous 
addition of 2.0 mM t-arginine (~]). Results are expressed  as the mean 
of four different  experiments  _+  SEM. 
262  Induction of the Nitric Oxide Synthase Pathway in Human Hepatocytes Table  1.  NO2-/N03-  and cGMP Levels in Supernatants of Human Hepatocyte Stimulated with Various Cytokines and LPS 
24 h  48 h 
Treatment  cGMP  cGMP 
Signal  (0.1  mM NMA)  NOn-/NO3-  (per 2  x  10  s hepatocytes)  NOn-/NO3-  (per 2  x  105 hepatocytes) 
ItM  fmol  ~M  fmol 
Medium  -  8.3  +  2.2#  92.0  +  5.8  14.1  •  0.8  79.5  •  4.8 
+  2.6  _+  0.1  31.0  •  7.0  2.1  •  0.02  <2.0 
rhTNF-ot  -  4.8  •  0.2  51.5  •  4.5  5.2  •  0.9  <2.0 
+  1.8  +_  0.1  <2.0  1.6  +_  0.3  <2.0 
rhlL-1  -  4.7  •  0.3  42.5  •  4.5  6.9  •  0.5  <2.0 
+  2.0  •  0.4  <2.0  3.1  _+ 0.6  <2.0 
rhlFN-y  -  5.1  •  0.3  <2.0  6.9  •  0.3  <2.0 
+  1.4  •  0.5  <2.0  1.7  +  0.2  <2,0 
LPS  -  4.7  •  0.2  <2.0  7.1  •  0.4  <2.0 
+  1.1  •  0.2  <2.0  2.4  •  0.5  <2.0 
CM  -  47.8  _+  2.1  420.5  •  23.2  125.2  •  7.3  321.5  •  7.3 
+  12.8  •  0.5  21.0  •  3.4  14.8  _+ 0.8  63.5  •  3.2 
* rhTNF-c~,  500 U/ml; rhlL-1, 5 U/ml; rhlFN-3,, 100 U/ml; LPS, 10/~g/ml; CM, all four signals combined. 
* Values represent  the mean  _+  SEM for  triplicate cultures  for one of three  similar experiments. 
The combination of  L-arginine with NADPH resulted in 3.50 
nmol/mg protein/3 h, while the addition of FAD (4 #M) 
and tetrahydrobiopterin (5 #M) increased NO production to 
24.10 nmol/mg protein/3 h. The addition of EDTA had no 
effect on  HC  cytosol NOS  activity and  the  addition of 
NADPH and t-arginine to cytosol obtained from unstimu- 
lated HC showed no NO generation (data not shown). These 
data show that human HC cytosolic enzyme activity does 
require NADPH and that cytosol from human HC in cul- 
ture may be more dependent on added FAD and tetrahydrobi- 
opterin than reported for freshly isolated rat HC (10). 
The data presented here provide evidence for the existence 
of inducible NOS in a human cell type. A recent publication 
showed NO2-  production in human monocytes (21). Un- 
like our findings in which human HC respond in a similar 
manner to rodent HC in terms of signals  and time course, 
human monocytes exhibited marked differences  compared with 
murine macrophages. Instead of  responding to LPS and IFN-3' 
within hours, as seen in rodent cells, human monocytes re- 
quired up to 5 d of stimulation with colony-stimulating  factor 
and TNF for induction of detectable NO2-  levels (22). The 
finding of the more typical type of inducible NOS in human 
HC obtained from histologically normal liver provides  sup- 
port for an inducible source of NO to explain the elevated 
nitrogen oxide levels in septic and cytokine-treated patients 
(22,  23).  Recent identification of a constitutively expressed 
NOS that is Ca  2+  independent from human colon adeno- 
carcinoma cell lines suggests that certain human tumor cells 
may contain a unique NOS or may continuously express an 
NOS with inducible characteristics  (24).  Even though our 
data suggest that inducible HC NO may serve as a signaling 
molecule for cGMP production, the actual physiologic and 
pathologic significance of NO production in human HC is 
unknown and its role in the liver remains to be determined. 
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